Wells Fargo & Company West Pharmaceutical Services Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Wells Fargo & Company holds 128,860 shares of WST stock, worth $42.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

128,860

Previous 122,333 5.34%

Holding current value

$42.9 Million

Previous $40.3 Million 4.02%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$277.16 - $333.3 $1.81 Million - $2.18 Million	6,527 Added 5.34%	128,860 $38.7 Million
Q2 2024 Aug 13, 2024	SELL	$314.68 - $395.94 $3.5 Million - $4.41 Million	-11,135 Reduced 8.34%	122,333 $40.3 Million
Q1 2024 May 10, 2024	BUY	$338.27 - $413.0 $6.39 Million - $7.8 Million	18,876 Added 16.47%	133,468 $52.8 Million
Q4 2023 Feb 09, 2024	SELL	$318.29 - $392.21 $355,211 - $437,706	-1,116 Reduced 0.96%	114,592 $40.4 Million
Q3 2023 Nov 13, 2023	SELL	$354.9 - $412.41 $11.4 Million - $13.3 Million	-32,133 Reduced 21.73%	115,708 $43.4 Million
Q2 2023 Aug 15, 2023	BUY	$334.63 - $382.47 $3.13 Million - $3.58 Million	9,355 Added 6.76%	147,841 $56.5 Million
Q1 2023 May 12, 2023	BUY	$232.5 - $346.47 $1.81 Million - $2.7 Million	7,795 Added 5.96%	138,486 $48 Million
Q4 2022 Feb 13, 2023	BUY	$209.34 - $261.61 $7.01 Million - $8.75 Million	33,464 Added 34.42%	130,691 $30.8 Million
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $262,321 - $366,330	1,066 Added 1.11%	97,227 $23.9 Million
Q2 2022 Aug 12, 2022	SELL	$280.61 - $420.45 $11.3 Million - $17 Million	-40,391 Reduced 29.58%	96,161 $29.1 Million
Q1 2022 May 16, 2022	BUY	$357.49 - $445.92 $3.44 Million - $4.3 Million	9,634 Added 7.59%	136,552 $56.1 Million
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $47 Million - $55 Million	-116,720 Reduced 47.91%	126,918 $59.5 Million
Q3 2021 Nov 15, 2021	SELL	$363.01 - $468.47 $8.22 Million - $10.6 Million	-22,633 Reduced 8.5%	243,638 $103 Million
Q2 2021 Aug 16, 2021	SELL	$284.77 - $363.2 $20.2 Million - $25.7 Million	-70,825 Reduced 21.01%	266,271 $95.6 Million
Q1 2021 May 13, 2021	BUY	$257.29 - $307.53 $168,524 - $201,432	655 Added 0.19%	337,096 $95 Million
Q4 2020 Feb 09, 2021	SELL	$261.16 - $301.66 $47.6 Million - $55 Million	-182,341 Reduced 35.15%	336,441 $95.3 Million
Q3 2020 Nov 05, 2020	SELL	$224.99 - $288.02 $47 Million - $60.2 Million	-209,090 Reduced 28.73%	518,782 $143 Million
Q2 2020 Aug 13, 2020	BUY	$149.8 - $227.17 $40.8 Million - $61.9 Million	272,467 Added 59.83%	727,872 $165 Million
Q1 2020 May 14, 2020	BUY	$128.96 - $174.76 $58.7 Million - $79.6 Million	455,405 New	455,405 $69.3 Million

Others Institutions Holding WST

# of Institutions

802

Shares Held

64.3M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.6B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company West Pharmaceutical Services Inc Transaction History